Eskayef is one of the leading pharmaceutical companies in Bangladesh with global accredititations of UK MHRA, EU GMP, VMD UK, TGA Australia, ANVISA Brazil etc. The history of Eskayef traces back to 1979, when the company was incorporated in Bangladesh as a subsidiary of the world-renowned multinational pharmaceutical comapany, SK&F (SmithKline & French ,USA) .
In 1990, Bangladesh operation of SK&F was acquired by Transcom Group in the wake of the merger between SmithKline & French, USA and Beecham, UK. That was the first instance of taking over of any multinational company by a Bangladeshi entity. After the acquisition, the new company was named Eskayef Bangladesh Limited. As Eskayef continued to increase its global presence, in 2017, it was renamed as Eskayef Pharmaceuticals Ltd. At present, Eskayef has global presence in 65 countries across Europe, America, Australia, Africa and Asia.
Eskayef manufactures and markets a wide range of therapeutic drugs, bulk pellets and animal health and nutrition products. Over the years, it has emerged as one of the most trusted, quality driven and scientific information based companies in the eyes of doctors and patients.